Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper
暂无分享,去创建一个
P. van Paassen | P. Vermeersch | M. Mahler | D. Blockmans | X. Bossuyt | J. C. Cohen Tervaert | J. Damoiseaux | M. López-Hoyos | B. Baslund | E. Csernok | N. Rasmussen | W. Schlumberger | D. Roggenbuck | J. Rönnelid | B. Hellmich | M. Vercammen | Walter Fierz | U. Leinfelder | R. Walker | F. Hammar | E. Barret | Nina Olschowka
[1] M. Mahler,et al. Standardisation of PR3-ANCA and MPO-ANCA: evaluation of certified reference materials , 2020, Annals of the Rheumatic Diseases.
[2] M. Fritzler,et al. Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios. , 2019, Autoimmunity reviews.
[3] Walter Fierz. Likelihood ratios of quantitative laboratory results in medical diagnosis: The application of Bézier curves in ROC analysis , 2018, PloS one.
[4] C. Kallenberg,et al. University of Groningen Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Bossuyt, , 2017 .
[5] P. van Paassen,et al. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies , 2017, Rheumatology.
[6] P. van Paassen,et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays , 2016, Annals of the rheumatic diseases.